ENDP Stock Price, Endo International Stock Quotes and News benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Endo Reports First-Quarter 2021 Financial Results And Updates 2021 Financial Guidance
DUBLIN, May 6, 2021 /PRNewswire/ Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2021. I am proud of the continued strong execution across each of Endo s business segments as reflected by our better than expected first-quarter 2021 results. During the quarter, our Branded Pharmaceuticals segment returned to growth, driven by strong demand for XIAFLEX and other physician administered products, said Blaise Coleman, President and Chief Executive Officer at Endo. In addition, we continued executing against our ongoing business transformation initiatives and achieved an important strategic milestone with the launch of QWO
Operator
Good morning, ladies and gentlemen, and welcome to the Fourth Quarter 2020 Endo International plc Earnings Conference Call.[Operator Instructions]
I would now like to turn the conference over to your host, Ms. Laure Park, Vice President, Investor Relations and Corp Affairs. Please go ahead.
Laure Park
Senior Vice President, Investor Relations and Corporate Affairs
Good morning and thank you for joining us to discuss our fourth quarter and full year 2020 financial results. Joining me on today s call are Blaise Coleman, President and CEO of Endo; Mark Bradley, Executive Vice President and CFO; and Patrick Barry, Executive Vice President and President, Global Commercial Operations.
Share this article
Share this article
DUBLIN, Feb. 25, 2021 /PRNewswire/ Endo International plc (NASDAQ: ENDP) today reported financial results for the fourth-quarter and full-year ended December 31, 2020 and introduced 2021 financial guidance. I am proud of all that the Endo team achieved in a very challenging year. We made significant progress in advancing our strategic priorities, delivered solid financial performance, rapidly responded to the COVID-19 pandemic and advanced our ESG-related actions, said Blaise Coleman, President and Chief Executive Officer at Endo. Looking ahead, we remain committed to expanding and enhancing our portfolio through focused investments, including the anticipated spring 2021 launch of QWO